Amphora Medical is a technology company.
Amphora Medical has raised $36.0M across 1 funding round.
Amphora Medical has raised $36.0M in total across 1 funding round.
Amphora Health is a Mexican health tech company building an ecosystem of AI-powered software solutions to drive digital transformation in Latin American healthcare. It develops products like Beluga Science® (a modern data warehouse for clinical and biorepository data), Vaquita EHR® (an NLP-enhanced electronic health record system focused on user efficiency), and Coral DX (a digital experience agency for health clients), serving healthcare providers, researchers, and biobanks to optimize clinical management, reduce administrative burdens, and enable data-driven insights.[1][4][7]
These tools address key challenges in emerging markets, such as data silos, inefficient workflows, and limited access to advanced analytics, with a SaaS model offering international best practices at low cost. The company has shown growth through public launches like Vaquita EHR, corporate restructuring for scalability, and international bioinformatics projects, positioning it as a leader in regional health tech.[4][5]
Amphora Health was founded in Morelia, Mexico, by co-founders Arturo (a data scientist with experience at Stanford and Genentech) and Pedro (with 15 years in software development at Cantera Digital and journalism background), classmates from Tecnológico de Monterrey's Computer Engineering program.[4]
The idea emerged during the COVID-19 pandemic, when they identified the urgent need for accessible health data analysis and dashboards in Michoacán, starting with Beluga Science as a no-code health data exploration tool that evolved into an intelligent repository. Early traction came from international bioinformatics projects, followed by key milestones like transforming into a SAPI (Investment Promotion Company) for growth and publicly launching Vaquita EHR as a SaaS platform.[4]
(Note: Search results also reference a separate U.S.-based Amphora Medical, founded in 2011, focused on medical devices for overactive bladder treatment and backed by $35.5M Series B funding, but it appears distinct from this Latin American software firm.[2][3][6])
Amphora Health rides the wave of digital health transformation in Latin America, where aging populations, rising chronic diseases, and post-COVID data demands create urgent needs for interoperable tech amid limited infrastructure.[1][4][7] Timing is ideal as regional governments push telemedicine and AI adoption, with market forces like increasing smartphone penetration and bioinformatics demand favoring scalable SaaS over hardware-heavy solutions.
It influences the ecosystem by democratizing advanced tools—e.g., low-cost EHRs reduce clinician burnout, while Beluga enables local research hubs—fostering a data-rich environment that attracts investment and accelerates LatAm's integration into global health innovation.[4][5]
Amphora Health is poised for expansion with its SAPI structure enabling funding rounds and product scaling, potentially dominating LatAm's EHR and data warehouse markets through AI enhancements and partnerships.[4] Trends like AI-driven precision medicine and regional data sovereignty will propel growth, evolving its influence from a Michoacán startup to a pan-LatAm platform powering cross-border research and clinical trials. As digital health demand surges, expect acquisitions or integrations with global players, solidifying its role in efficient, insight-led care that began with pandemic-inspired data needs.
Amphora Medical has raised $36.0M in total across 1 funding round.
Amphora Medical's investors include Baird Capital, F-Prime Capital Partners, George Rehm.
Amphora Medical has raised $36.0M across 1 funding round. Most recently, it raised $36.0M Series B in July 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2017 | $36.0M Series B | Baird Capital, F-Prime Capital Partners, George Rehm |